Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | GSK3B | P49841 | 2/20 | 0.44 |
| ▸ | OGG1 | O15527 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123450 | 0.82 | CES2 (0.54) | CES2CES1CA1CA2GSK3B | |
| SCHEMBL6343638 | 0.81 | MAPT (0.55) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL5049280 | 0.81 | MAPT (0.55) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL1380046 | 0.80 | CES2 (0.52) | CES2CES1CA1CA2GSK3B | |
| SCHEMBL15054815 | 0.80 | CES2 (0.52) | CES2CES1CA1CA2GSK3B | |
| SCHEMBL17547225 | 0.79 | CES2 (0.50) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL14596409 | 0.79 | CES2 (0.50) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL206782 | 0.77 | CES2 (0.48) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL942286 | 0.77 | CES2 (0.48) | CES2CES1CYP2A6CA1CA2 | |
| SCHEMBL6036757 | 0.77 | CES2 (0.48) | CES2CES1CYP2A6CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048162-A1 | PREPARATION METHOD FOR CONJUGATED DIENE COMPOUND | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2020-02-13 | — | — | US | disclosed |
| US-20200048162-A1 | PREPARATION METHOD FOR CONJUGATED DIENE COMPOUND | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048162-A1 | PREPARATION METHOD FOR CONJUGATED DIENE COMPOUND | ACR, SQLE, FDFT1 | CES2 2922/4885CES1 2955/4885CYP2A6 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.